Cash and Cash Equivalents, at Carrying Value of ARTELO BIOSCIENCES, INC. from 28 Feb 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
ARTELO BIOSCIENCES, INC. quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 28 Feb 2014 to 31 Dec 2025.
  • ARTELO BIOSCIENCES, INC. Cash and Cash Equivalents, at Carrying Value for the quarter ending 31 Dec 2025 was $600,000.
Source SEC data
View on sec.gov
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

ARTELO BIOSCIENCES, INC. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $600,000 31 Dec 2025 8-K 17 Mar 2026
Q3 2023 $2,639,000 -$4,497,000 -63% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $5,719,000 -$6,403,000 -53% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $6,916,000 -$3,434,000 -33% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $6,888,000 -$5,274,000 -43% 31 Dec 2022 10-Q 13 Nov 2023 2023 Q3
Q3 2022 $7,136,000 +$507,000 +7.6% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $12,122,000 +$5,812,000 +92% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $10,350,000 +$2,337,000 +29% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $12,162,000 +$6,379,000 +110% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $6,629,000 +$4,487,000 +209% 31 Aug 2021 10-K 31 Mar 2023 2022 FY
Q2 2021 $6,310,000 +$5,030,744 +393% 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $8,013,000 +$6,030,453 +304% 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $5,783,000 +$2,408,317 +71% 31 Dec 2020 10-Q 09 Aug 2022 2022 Q2
Q3 2020 $2,142,000 -$2,282,000 -52% 31 Aug 2020 10-KT 21 Mar 2022 2022 Q1
Q2 2020 $1,279,256 +$992,817 +347% 31 May 2020 10-Q 12 Jul 2021 2021 Q3
Q1 2020 $1,982,547 +$1,525,219 +334% 29 Feb 2020 10-Q 13 Apr 2021 2021 Q2
Q4 2019 $3,374,683 +$3,259,609 +2833% 30 Nov 2019 10-Q 14 Jan 2021 2021 Q1
Q3 2019 $4,424,000 +$4,086,576 +1211% 31 Aug 2019 10-KT 21 Mar 2022 2022 Q1
Q2 2019 $286,439 -$39,584 -12% 31 May 2019 10-Q 13 Jul 2020 2020 Q3
Q1 2019 $457,328 -$67,779 -13% 28 Feb 2019 10-Q 13 Apr 2020 2020 Q2
Q4 2018 $115,074 -$297,366 -72% 30 Nov 2018 10-Q 14 Jan 2020 2020 Q1
Q3 2018 $337,424 -$235,351 -41% 31 Aug 2018 10-K 04 Nov 2020 2020 FY
Q2 2018 $326,023 +$98,185 +43% 31 May 2018 10-Q 15 Jul 2019 2019 Q3
Q1 2018 $525,107 +$514,210 +4719% 28 Feb 2018 10-Q 15 Apr 2019 2019 Q2
Q4 2017 $412,440 +$408,850 +11389% 30 Nov 2017 10-Q 14 Jan 2019 2019 Q1
Q3 2017 $572,775 +$569,185 +15855% 31 Aug 2017 10-K/A 18 Dec 2019 2019 FY
Q2 2017 $227,838 +$224,248 +6246% 31 May 2017 10-Q 13 Jul 2018 2018 Q3
Q1 2017 $10,897 +$7,307 +204% 28 Feb 2017 10-Q/A 14 May 2018 2018 Q2
Q4 2016 $3,590 -$381 -9.6% 30 Nov 2016 10-Q/A 21 Mar 2018 2018 Q1
Q3 2016 $3,590 -$13,439 -79% 31 Aug 2016 10-K 29 Nov 2018 2018 FY
Q2 2016 $3,590 -$8,991 -71% 31 May 2016 10-Q 21 Jul 2017 2017 Q3
Q1 2016 $3,590 -$4,491 -56% 29 Feb 2016 10-Q 14 Apr 2017 2017 Q2
Q4 2015 $3,971 -$10,260 -72% 30 Nov 2015 10-Q 10 Jan 2017 2017 Q1
Q3 2015 $17,029 +$2,298 +16% 31 Aug 2015 10-K 29 Nov 2017 2017 FY
Q2 2015 $12,581 -$2,674 -18% 31 May 2015 10-Q 05 Jul 2016 2016 Q3
Q1 2015 $8,081 -$21,824 -73% 28 Feb 2015 10-Q 01 Apr 2016 2016 Q2
Q4 2014 $14,231 30 Nov 2014 10-Q 14 Jan 2016 2016 Q1
Q3 2014 $14,731 31 Aug 2014 10-K 29 Nov 2016 2016 FY
Q2 2014 $15,255 31 May 2014 10-Q 15 Jul 2015 2015 Q3
Q1 2014 $29,905 28 Feb 2014 10-Q 14 Apr 2015 2015 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.